Clinical Trial Update: CBD for Breast Cancer Primary Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating cannabidiol (CBD) for primary tumors in breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING